Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study. Read more about Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study.
Genomic features underlying meningioma sex-specificity. Read more about Genomic features underlying meningioma sex-specificity.
Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad Scope and Implementation - A Progress Report. Read more about Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad Scope and Implementation - A Progress Report.
The TCR Repertoire: A Window Into Pediatric Brain Tumor Immunity. Read more about The TCR Repertoire: A Window Into Pediatric Brain Tumor Immunity.
Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiative. Read more about Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiative.
Dual αVβ8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Glioma Immunity. Read more about Dual αVβ8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Glioma Immunity.
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1. Read more about Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1.
Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy. Read more about Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy.
A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence. Read more about A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence.
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas. Read more about cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.
